Kanyin Liane Ong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kanyin Liane Ong has a total of 805 co-authors. Here are the top co-authors by number of shared publications:
Theo Vos
Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
2 shared publicationsAbazar Roustazadeh
1 shared publicationAbdallah Y Naser
1 shared publicationAbderrahim Oulhaj
1 shared publicationAbdollah Jafarzadeh
1 shared publicationAbdollah Mohammadian-Hafshejani
1 shared publication
Latest Publications
- Open Access
- 7 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer
Cancer is a major public health problem strongly influenced by genetic factors and aging; however, a proportion of its burden can be attributed to potentially modifiable risk factors. We undertook a systematic review and meta-analysis of the existing evidence to quantify and assess the relationship between high fasting plasma glucose (FPG) levels and the risk of developing and dying for seven types of cancer (selected for having attributable burden from FPG in GBD). Using Burden of Proof methods that provide a conservative interpretation of the evidence, we found moderate relationships between high FPG and the risk of breast, pancreatic, and colorectal cancer. Weak relationships were observed with bladder, liver, ovarian, and tracheal, bronchus and lung cancers. These findings should galvanize the global community’s efforts in addressing the increasing burden of high blood sugar and inform the potential impact of different hypoglycemic treatments on reducing the burden of cancer.
- 7 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Open AccessA burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer
Cancer is a major public health problem strongly influenced by genetic factors and aging; however, a proportion of its burden can be attributed to potentially modifiable risk factors. We undertook a systematic review and meta-analysis of the existing evidence to quantify and assess the relationship between high fasting plasma glucose (FPG) levels and the risk of developing and dying for seven types of cancer (selected for having attributable burden from FPG in GBD). Using Burden of Proof methods that provide a conservative interpretation of the evidence, we found moderate relationships between high FPG and the risk of breast, pancreatic, and colorectal cancer. Weak relationships were observed with bladder, liver, ovarian, and tracheal, bronchus and lung cancers. These findings should galvanize the global community’s efforts in addressing the increasing burden of high blood sugar and inform the potential impact of different hypoglycemic treatments on reducing the burden of cancer.
- Top Cited PapersOpen Access
- 23 June 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10397) , 203-234
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
- 23 June 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10397) , 203-234
Top Cited PapersOpen AccessGlobal, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021